Therefore, butyrate resistance might be attributable to the changes in the expression of tumorigenic and/or pro-apoptotic proteins rather than changes in the expression of P-gp or BCRP, which were found comparable between PT and BR colon cancer cells. This evidence concerns the gene ABCG2 and malignant colon neoplasm.